CD8A and myeloid neoplasm: On the basis of these findings, we have conducted an early phase I/II study in which we have trialed the use of third-party, pooled granulocyte transfusions in conjunction with CBT to promote CD8+ expansion in children with high-risk myeloid malignancy (93).